Furthermore, research indicates that triptolide can also induce cuproptosis, presenting a novel antitumor strategy for cervical cancer by specifically targeting the X-Linked inhibitor of apoptosis (XIAP) (71) (Figure 1C). Here, XIAP is linked to cervical carcinoma.